ArticleAmerican journal of ophthalmology case reports2021

Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter study.

Connie M Sears et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.